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Tenofovir (TFV) is the first-line agent in the treatment of hepatitis B virus (HBV) 
infection for patients aged over 12 years and one of the first-line choices for the 
combination antiretroviral therapy (cART) of infections caused by human 
immunodeficiency virus (HIV).  
Two commercially available prodrugs have been developed for oral administration of 
TFV, tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide fumarate (TAF). 
These prodrugs increase TFV membrane permeability and oral bioavailability.  
One of the factors that can affect the bioavailability of orally administrated drugs is active 
transport mediated by efflux transporters, mainly by P-glycoprotein (ABCB1, P-gp) and 
Breast cancer resistance protein (ABCG2, BCRP). It has been already proved that TDF 
and TAF are substrates of both of these transporters.  
The goal of this diploma thesis was to use in vitro and ex vivo models of intestinal barrier 
to assess the impact of the efflux transporters on TDF and TAF transport in the intestine 
and on their accumulation in rat precision-cut intestinal slices (rPCIS). We also focused 
on comparing the stability and metabolism of TDF and TAF in the rat intestine.  
Data from our studies on Caco-2 cell line (human epithelial colorectal adenocarcinoma 
cells) confirmed that both TDF and TAF are substrates of efflux transporter ABCB1. 
Specific inhibition of ABCG2 did not affect TDF and TAF transport across Caco-2 cell 
monolayer. Effect of ABCB1 inhibition was also seen using rPCIS. ABCB1 inhibition 
resulted in increased accumulation of TDF and TAF metabolites in rPCIS. Data from our 
studies on rPCIS also confirmed that TDF is in intestine less stable than TAF and is 
rapidly metabolized by gut hydrolases.  
